Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Evelo Biosciences stock
Learn how to easily invest in Evelo Biosciences stock.
Evelo Biosciences is a biotechnology business based in the US. Evelo Biosciences shares (EVLO) are listed on the NASDAQ and all prices are listed in US Dollars. Evelo Biosciences employs 66 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy Evelo Biosciences stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – EVLO. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
- Easy to use platform with $0 stock trading & no annual fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+
Evelo Biosciences stock price (NASDAQ: EVLO)Use our graph to track the performance of EVLO stocks over time.
Evelo Biosciences shares at a glance
|Latest market close||$0.20|
|52-week range||$0.20 - $4.36|
|50-day moving average||$0.76|
|200-day moving average||$1.76|
|Wall St. target price||$1.40|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-1.16|
Buy Evelo Biosciences stocks from these online trading platformsCompare special offers, low fees and a wide range of investment options among top trading platforms.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Is it a good time to buy Evelo Biosciences stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Evelo Biosciences price performance over time
Historical closes compared with the close of $0.196 from 2023-03-29
|1 week (2023-03-23)||-4.72%|
|1 month (2023-03-02)||-64.84%|
|3 months (2022-12-30)||-87.83%|
|6 months (2022-09-30)||-90.62%|
|1 year (2022-03-26)||N/A|
|2 years (2021-03-30)||-98.11%|
|3 years (2020-03-30)||3.85|
|5 years (2018-03-26)||N/A|
Evelo Biosciences financials
|Gross profit TTM||$0|
|Return on assets TTM||-89.02%|
|Return on equity TTM||-6232.76%|
|Market capitalisation||$25.1 million|
TTM: trailing 12 months
Evelo Biosciences share dividends
We're not expecting Evelo Biosciences to pay a dividend over the next 12 months.
Evelo Biosciences share price volatility
Over the last 12 months, Evelo Biosciences's shares have ranged in value from as little as $0.2 up to $4.36. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Evelo Biosciences's is 1.377. This would suggest that Evelo Biosciences's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Evelo Biosciences overview
Evelo Biosciences, Inc. , a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hyperinflammatory response associated with COVID-19. The company also develops EDP1867, an inactivated investigational oral biologic, which is in Phase 1b for the treatment of inflammatory diseases; EDP2939, an extracellular vesicle investigational oral biologic for the treatment of inflammatory diseases; and EDP1908, a product candidate for oncology. Evelo Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts. .
Evelo Biosciences in the news
Evelo Biosciences, Inc. (NASDAQ:EVLO) Q4 2022 Earnings Call Transcript
Q4 2022 Evelo Biosciences Inc Earnings Call
Evelo Biosciences Announces Fourth Quarter and Full Year 2022 Financial Results and Business Highlights
Frequently asked questionsWhat percentage of Evelo Biosciences is owned by insiders or institutions?
Currently 0.127% of Evelo Biosciences shares are held by insiders and 83.687% by institutions. How many people work for Evelo Biosciences?
Latest data suggests 66 work at Evelo Biosciences. When does the fiscal year end for Evelo Biosciences?
Evelo Biosciences's fiscal year ends in December. Where is Evelo Biosciences based?
Evelo Biosciences's address is: 620 Memorial Drive, Cambridge, MA, United States, 02139 What is Evelo Biosciences's ISIN number?
Evelo Biosciences's international securities identification number is: US2997341035 What is Evelo Biosciences's CUSIP number?
Evelo Biosciences's Committee on Uniform Securities Identification Procedures number is: 299734103
More guides on Finder
What happens if a brokerage firm fails?
Here’s what happens to your securities if your brokerage fails, and how your assets are protected by SIPC and FDIC.
How to Buy Gold Stocks
Learn about buying physical gold, plus stocks and ETFs, to learn how you can add gold exposure to your portfolio.
Silicon Valley Bank collapse: Which ETFs and stocks are impacted?
Several ETFs have exposure to Silicon Valley Bank, but it appears minimal.
How to Buy Treasury Bills
Treasury Bills are fixed-income assets with maturities of less than one year. Here’s what to know before investing.
SVB collapses: What does it mean for your portfolio?
The 16th largest US bank has collapsed, but its impact on your portfolio could be limited depending on what you own.
How to buy Vanguard VTI Total Stock Market ETF units
Steps to investing in the Vanguard (VTI) Total Stock Market ETF.
How to buy Neuraxis (NRXS) stock when it goes public
Everything we know about the Neuraxis IPO, plus information on how to buy in.
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
Ask an Expert